The national immunisation programme in the Netherlands is very effective and safe. To improve the success and effectiveness of the immunisation programme, vaccination of other (age)groups is indicated. Extension of the programme with new target diseases can result in considerable health gain for some diseases. The target diseases are largely under control. However, monitoring the effectiveness of the programme is important. Maintaining high vaccin uptake is vital to prevent (re)emergence of disease. Vaccination of (young) adults now (pertussis) and in the future (mumps, measles, rubella, hepatitis B) could give further improvement. Also other vaccination strategies need attention such as maternal or newborn vaccination for pertussis. The...
This document provides an overview of the occurrence of the target diseases included in the National...
The 2014-2015 report presents the following findings: As in previous years, the vaccination coverage...
Het Rijksvaccinatieprogramma in Nederland is zeer effectief en veilig. Om het succes en de effectivi...
The national immunisation programme in the Netherlands is very effective and safe. To improve the su...
The National Immunisation Programme in the Netherlands is effective and safe. The target diseases ar...
The National Immunisation Programme in the Netherlands is effective and safe. The target diseases ar...
In 2006 several changes were made in the Dutch National Immunisation Programme (NIP): Hepatitis B va...
Under the National Immunisation Programme (NIP), 1,520,301 children and pregnant women were vaccinat...
In 2017, about 760,000 children aged 0 to 19 years received a total of 2,140,000 vaccinations within...
A view is presented on the future vaccination policy in the Netherlands. The report addresses the fo...
A view is presented on the future vaccination policy in the Netherlands. The report addresses the ...
Het Rijksvaccinatieprogramma in Nederland is effectief en veilig. De ziekten waartegen momenteel wor...
Surveillance and developments in 2016-2017 In 2016, about 760,000 children aged 0 to 19 years receiv...
In 2005 national coverage levels for all vaccines used in the Netherlands showed a further increase ...
This report describes the progress of the National Immunization Programme (NIP) in the Netherlands. ...
This document provides an overview of the occurrence of the target diseases included in the National...
The 2014-2015 report presents the following findings: As in previous years, the vaccination coverage...
Het Rijksvaccinatieprogramma in Nederland is zeer effectief en veilig. Om het succes en de effectivi...
The national immunisation programme in the Netherlands is very effective and safe. To improve the su...
The National Immunisation Programme in the Netherlands is effective and safe. The target diseases ar...
The National Immunisation Programme in the Netherlands is effective and safe. The target diseases ar...
In 2006 several changes were made in the Dutch National Immunisation Programme (NIP): Hepatitis B va...
Under the National Immunisation Programme (NIP), 1,520,301 children and pregnant women were vaccinat...
In 2017, about 760,000 children aged 0 to 19 years received a total of 2,140,000 vaccinations within...
A view is presented on the future vaccination policy in the Netherlands. The report addresses the fo...
A view is presented on the future vaccination policy in the Netherlands. The report addresses the ...
Het Rijksvaccinatieprogramma in Nederland is effectief en veilig. De ziekten waartegen momenteel wor...
Surveillance and developments in 2016-2017 In 2016, about 760,000 children aged 0 to 19 years receiv...
In 2005 national coverage levels for all vaccines used in the Netherlands showed a further increase ...
This report describes the progress of the National Immunization Programme (NIP) in the Netherlands. ...
This document provides an overview of the occurrence of the target diseases included in the National...
The 2014-2015 report presents the following findings: As in previous years, the vaccination coverage...
Het Rijksvaccinatieprogramma in Nederland is zeer effectief en veilig. Om het succes en de effectivi...